Amgen's esults from its Phase 2, open-label ALCANTARA study evaluating the efficacy and safety of BLINCYTO has been published in the Journal of Clinical Oncology. Read More »

A group representing pharmacy benefit managers is criticizing a report by a drug industry lobbying group that concludes the managers are not passing along drug rebates and discounts to patients. Read More »

Cumberland Pharmaceuticals Inc.'s open label multicenter study, published in Drug Design, Development and Therapy, supports the efficacy and use of Vaprisol Injection for treating hyponatremic patients with severe hepatic impairment. Read More »

CVS Health has launched a prescription savings program called Reduced RX that will provide various discounts for certain medications through CVS Caremark directly to patients. Read More »

Teva Pharmaceuticals Industries Ltd. has launched its authorized generic of Minastrin 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) 1 mg/20 mcg in the U.S. Read More »

Sanofi Healthcare, the company behind Xyzal Allergy 24HR, recently announced the results of an allergy-related social experiment involving 160 participants who wore wearable devices for 30 days to track sleep and activity. Read More »

Sen. Ron Wyden (D-OR) last week introduced legislation that he says would increase pricing "transparency" among pharmacy benefit managers.  Read More »

Diplomat Pharmacy Inc. recently announced that it will dispense KISQALI as a first-line treatment for postmenopausal women with serious forms of breast cancer. Read More »

Amgen’s recent Phase 3 study of the effects of Repatha on patients who receive apheresis for low-density lipoprotein cholesterol showed a promising reduction in the need for the recurring procedure. Read More »

The American Society of Health-System Pharmacists (ASHP) recently announced that the current Alabama legislature session is seeking to attempt to have the state codify collaborative drug therapy management (CDMT) as part of pharmacy practice. Read More »

U.S. House Judiciary Chairman Bob Goodlatte (R-VA) has sent letters to the American Bar Association and every state bar association, urging the organizations to adopt requirements for warnings on trial lawyer advertisements that urge patients to discontinue the use of some medicines. Read More »

U.S. Congressmen Doug Collins (R-GA) and Dave Loebsack (D-IA) last week introduced a bill -- H.R. 1316, the Prescription Drug Price Transparency Act -- that they say would "require greater transparency from pharmacy benefit managers (PBMs)." In introducing the bill, the congressmen, along with Rep. Buddy Carter (R-GA) and others, took to the House floor to deliver what Drug Channels' Dr. Adam Fein referred to as a "60-minute rant" against PBMs. Read More »

According to a recent PRNewswire release, CVS Pharmacy is the first national retail pharmacy chain to remove trans fat from their store brand food products.  Read More »

CVS Health Research Institute recently released a statement on its decision to stop selling tobacco products and the research behind that decision.  Read More »

The Association for Accessible Medicines (AAM) recently announced that its president and CEO, Chip Davis, made a statement regarding the confirmation of Tom Price as Secretary of Health and Human Services. Read More »

Prime Therapeutics releases report showing it held drug costs increases to just 2.5 percent for its clients in 2015. Read More »

"I'm thankful that we have the PBMs in the Part D program that are performing that negotiation on behalf of seniors." -- Seema Verma, nominee to serve as administrator of the Centers for Medicare and Medicaid Services Read More »

The listed price for brand-name drugs increased 11 percent last year, but the largest pharmacy benefits manager in the U.S. said it shielded employers it works with from the bulk of that increase. Read More »

Pharmaceutical companies, trial lawyers and tort reform advocates are closely following a case that the U.S. Supreme Court has taken up that addresses the issue of plaintiffs joining suits in other states. Read More »

Nationwide mail-order pharmacy giant Express Scripts recently revealed successful limits to 2016 drug spending — yielding a 27 percent decrease over that of 2015 — from St. Louis as it released its annual Drug Trend Report. Read More »